Discover MabDesign

MabDesign, the French association of the industrial sector of biomedicines, aims to support, structure, federate and increase the visibility of the industrial sector of biological medicines.
carl-newton-2C6kAtCXf6U-unsplash

Access our network

Join the MabDesign network to take advantage of all the advantages and opportunities offered.
casey-horner-9vf1uj6i6Ww-unsplash

Develop your skills

Consult and register for our next training courses in order to acquire new expertise.
smartworks-coworking-Uz8THWPXwhI-unsplash

Explore our business services

The field of therapeutic antibodies and immunotherapy is growing rapidly. The French industrial ecosystem is rich in innovative companies with considerable potential. MabDesign’s mission is to support them in their development in France and abroad.
arlington-research-kN_kViDchA0-unsplash

Upcoming events

Add your title here

15
Apr.
April 15-17, 2025
Partner Event
28
Apr.
April 28-30, 2025
Partner Event
05
May.
May, 5-6 2025
Partner Event
02
Jun.
June 2nd, 2025
Mabdesign Event

Our News

1ère page Ypso-Facto

ZOOM ON - Ypso-Facto

Ypso-Facto helps pharmaceutical companies develop, optimize, and secure bioprocesses. By combining scientific expertise with industrial experience, we offer consulting services and innovative software solutions to enhance efficiency, sustainability, and performance in API process development and manufacturing.
LYO-X 1ère page

ZOOM ON - LYO-X

LYO-X is a consulting and modeling & simulation company specialized in PK/PD and Quantitative Systems Pharmacology for the preclinical, translational and clinical development of biologics and novel drug formats.
epigenelogo

EPIGENE LABS ANNOUNCES MULTI-YEAR EXPANSION OF COLLABORATIONWITH SERVIER TO ADVANCE AI-DRIVEN PRECISION ONCOLOGY R&D

Epigene Labs, a techbio company focused on creating intelligence-augmenting solutions for precision oncology, today announced an expanded multi-year collaboration with Servier, an independent international pharmaceutical group.
Pierre Fabre Institut de Recherche

Les Laboratoires Pierre Fabre et RedRidge Bio annoncent un partenariat concernant la découverte et le co-développement de candidats médicament

Les Laboratoires Pierre Fabre et RedRidge Bio (« RedRidge ») annoncent aujourd’hui une collaboration exclusive en R&D, ainsi qu'un contrat de licence en vue d'identifier et de développer des candidats-médicaments à base d'anticorps biparatopiques (ABP) contre plusieurs cibles.

OUR BOARD OF DIRECTORS